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        The role of human hepatic stem cells (hHpSCs), 
particularly in the maintenance and regenera-
tion of the adult liver, has been a subject of 
debate without a clear consensus (  1  –  11  ). Dur-
ing embryonic development, endodermal cells 
in the mid-region of the embryo bulge into 
the cardiac mesenchyme, are aff  ected by criti-
cal signaling from endothelia forming vascula-
ture, and form the liver bud (  6, 7  ). The cells 
within the liver bud are recognized as hepato-
blasts because of the expression of a signature 
marker,      -fetoprotein (AFP), and are bipotent, 
giving rise to hepatocytes and bile-duct epithe-
lial cells, which are called cholangiocytes (  11  ). 
We and others have described the isolation and 
expansion in culture of AFP  cells from fetal 
and adult livers of several species (  8  –  10  ). Clo-
nogenic expansion assays of rodent hepato-
blasts under wholly defi  ned conditions have 
demonstrated that hepatoblasts are capable of 
extensive expansion ex vivo, as well as diff  er-
entiation to both hepatocytic and biliary lin-
eages (  8  ). The fi  ndings from investigations of 
liver organogenesis, as well as the ex vivo stud-
ies of hepatoblasts, have led to a long-standing 
assumption that hHpSCs correspond to hepa-
toblasts, and that hHpSCs would express AFP. 
However, AFP  cells are rare in normal adult 
livers ( 0.01%), except in livers with severe 
injury or disease (  11  –  13  ). In addition, the re-
nowned replicative capacity of hepatocytes in 
vivo (  14  ) has led to the opinion that adult livers 
do not have hHpScs and that all regenerative 
responses are from mature parenchymal cells, 
except in certain disease states (  1  ). 
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  Human hepatic stem cells (hHpSCs), which are pluripotent precursors of hepatoblasts and 
thence of hepatocytic and biliary epithelia, are located in ductal plates in fetal livers and in 
Canals of Hering in adult livers. They can be isolated by immunoselection for epithelial cell 
adhesion molecule  –  positive (EpCAM+) cells, and they constitute     0.5  –  2.5% of liver pa-
renchyma of all donor ages. The self-renewal capacity of hHpSCs is indicated by phenotypic 
stability after expansion for  150 population doublings in a serum-free, defi  ned medium 
and with a doubling time of     36 h. Survival and proliferation of hHpSCs require paracrine 
signaling by hepatic stellate cells and/or angioblasts that coisolate with them. The hHpSCs 
are     9     m in diameter, express cytokeratins 8, 18, and 19, CD133/1, telomerase, CD44H, 
claudin 3, and albumin (weakly). They are negative for     -fetoprotein (AFP), intercellular 
adhesion molecule (ICAM) 1, and for markers of adult liver cells (cytochrome P450s), 
hemopoietic cells (CD45), and mesenchymal cells (vascular endothelial growth factor 
receptor and desmin). If transferred to STO feeders, hHpSCs give rise to hepatoblasts, which 
are recognizable by cordlike colony morphology and up-regulation of AFP, P4503A7, and 
ICAM1. Transplantation of freshly isolated EpCAM cells or of hHpSCs expanded in culture 
into NOD/SCID mice results in mature liver tissue expressing human-specifi  c proteins. The 
hHpSCs are candidates for liver cell therapies. 1974 HUMAN HEPATIC STEM CELLS | Schmelzer et al.
hepatoblasts, the distribution of CK19 is more particulate and 
less intense than that in ductal plate cells. EpCAM expression 
in AFP  cells, both in fetal and postnatal livers, occurred at 
the membrane only. In pediatric and adult livers, hepatoblasts 
were found as individual cells or small clusters of cells teth-
ered to the ends of the Canals of Hering (  Fig. 1  ). The hepa-
toblasts in nondiseased, postnatal livers constitute  0.01% of 
cells and express AFP weakly. 
  Flow cytometry of EpCAM+ cells 
  Using fl  ow cytometry, we observed EpCAM+ cells in human 
liver cell suspensions of all donor ages (  Fig. 2 A  ).   Suspensions 
from fetal livers from which hemopoietic cells had been 
purged contained, on average, 12% EpCAM  cells. How-
ever, the percentage could be as high as 20% depending on the 
gestational age of the fetus. Most of the EpCAM  cells in fe-
tal livers were of nonhepatic lineage and were predominantly 
hemopoietic. The vast majority ( 90%) of the EpCAM  
cells in fetal livers coexpress AFP, albumin, and CK19 (  Fig. 2  ). 
They could be subdivided into two subpopulations: (a) hepa-
toblasts showing expression of ICAM1, AFP, albumin, CK19, 
CD133/1, P450A7, and CD44H (hyaluronan receptor), and 
(b) hHpSCs, constituting     5% of EpCAM  cells from fetal 
  We defi  ne a novel class of AFP-negative cells in fetal and 
adult human livers that are precursors to hepatoblasts and 
have properties consistent with hHpSCs. The hHpSCs are 
negative for AFP, but positive for epithelial cell adhesion 
molecule (EpCAM; CD326, C017-1A antigen, and GA733-2). 
This protein, encoded by the tumor-associated calcium signal 
transducer 1 gene, is expressed by many carcinomas and 
serves a regulatory function in certain normal epithelia, in-
cluding all of those derived from endoderm (liver, lung, pan-
creas, and intestine) (  15, 16  ). By immunohistochemistry, 
Balzar et al. observed that hepatoblasts in embryonic hu-
man liver are EpCAM , whereas mature hepatocytes are 
EpCAM  (  15  ). In adult livers, most, but not all, bile duct 
epithelia are EpCAM . Also, expanded ductular structures, 
seen in cases of focal nodular hyperplasia or biliary cirrhosis, 
contain numerous EpCAM  cells (  15  ). 
  We have previously reported that EpCAM , AFP  cells 
from human livers are hHpSCs, and we have compared their 
pattern of gene expression with that of hepatoblasts and ma-
ture liver parenchyma (  17  ). We now show that the hHpSCs 
are located in ductal plates in fetal and neonatal livers and in 
the proximal branches of the intrahepatic biliary tree, the Ca-
nals of Hering, in pediatric and adult livers of all donor ages, 
with the frequency of hHpSCs remaining relatively constant 
throughout life. We further document the immunoselection 
of these cells using monoclonal antibodies to EpCAM and 
test whether they meet the defi  ning criteria for stem cells, 
i.e., self-renewal and pluripotency. 
    RESULTS   
  In vivo localization of EpCAM+ hHpSCs 
  Sections of fetal and adult livers were stained for EpCAM and 
for liver-specifi  c markers (albumin, AFP, and CK19;   Fig. 1  ).   
We found that ductal plates, bands of tissue encircling each of 
the portal triads in fetal and neonatal livers, have small cells 
(7  –  10      m) with a paucity of cytoplasm, and stained intensely 
both cytoplasmically and at the surface for CK19 and EpCAM, 
and weakly for albumin, but are negative for AFP. In non-
diseased, postnatal (pediatric and adult) livers, cells staining 
positively for EpCAM by immunohistochemistry appear ex-
clusively in the Canals of Hering in the vicinity of the portal 
triads of acini. Theise et al. (  18  ) reported that cells lining 
these ductules express cytokeratin (CK) 19, which is present 
in biliary epithelia, but not in hepatocytes. Our data confi  rm 
their study and demonstrate that the CK19  cells within the 
Canals of Hering express EpCAM, and that subpopulations 
of them also express albumin (  Fig. 1  ; yellow color is caused 
by overlap of CK19 and albumin expression). The coexpression 
of CK19 and albumin is consistent with hHpSCs and corrob-
orates the hypothesis of others that the Canals of Hering 
comprise a niche for hHpSCs (  19  ). Shown are data from ex 
vivo studies of EpCAM  cells supportive of the interpreta-
tion that they include hHpSCs. 
  Most parenchymal cells of fetal and neonatal livers con-
sisted of hepatoblasts, slightly larger cells (10  –  12      m in diam-
eter) that stained positively for albumin, AFP, and CK19. In 
  Figure 1.     Immunohistochemical studies on human fetal livers. 
Confocal microscopic images on 5- m liver sections. The antigenic pro-
fi  les are given in the table (bottom left). In human fetal livers, sections 
were stained for: EpCAM (green) and CK19 (red) (A); EpCAM (green) and 
AFP (red) (B); CK19 (green) and albumin (red) (C); CK19 (green) and AFP 
(red) (D). In adult livers, sections were stained for: EpCAM (E). (F) Canals of 
Hering around portal triad with EpCAM (green) and CK19 (red). (G) A Canal 
of Hering showing EpCAM+ cells (green), some of which also express 
albumin  (red).   JEM VOL. 204, August 6, 2007 
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cases of overt hepatic disease (e.g., cirrhosis; unpublished data). 
Neonatal livers, including some from premature births, showed 
rapidly decreasing levels of AFP  cells as a function of age, 
falling below detection level by a few months after birth. 
Based on considerations detailed in our study and from our 
previously published work (  17  ), we identify the EpCAM  cells 
from pediatric and adult livers as almost exclusively hHpSCs, 
not hepatoblasts. 
  Culture selection on plastic and in serum-free Kubota  ’  s 
medium (KM) isolates hHpSCs, but not hepatoblasts 
  Suspensions of liver cells plated in KM, which is a serum-free 
medium optimized for ex vivo expansion of hepatic progeni-
tors (  8  ), either on tissue culture plastic or on embryonic stromal 
livers, had an overlapping, but distinct, profi  le; they were pos-
itive for albumin (weak), CK19, CD44H, CD133/1 , neural 
cell adhesion molecule  –  positive (NCAM ), and claudin 3, 
but negative for AFP and P450A7. 
  Cell suspensions from adult human livers averaged 1.3% 
EpCAM+ cells, and those from neonatal and pediatric do-
nors two- to threefold higher. Preparations having EpCAM  
cell populations at levels  1.5% were typically obtained from 
livers subjected to ischemia (cold or warm) before organ pro-
curement and/or during transportation. This suggests that 
the EpCAM  liver cells are more resistant to ischemia than 
mature liver cells. The postnatal EpCAM  liver cells also 
coexpress CK19 and albumin (unpublished data), but have 
no detectable AFP  cells (by fl  ow cytometry), except in rare 
  Figure 2.     Flow cytometric characterization of EpCAM cells. (A) The percentage of EpCAM  cells in livers of varying donor ages. The numbers 
for fetal livers have been previously reported (  28  ), but are presented here for comparison to fi  ndings in livers from older donors. (B) Analyses of EpCAM  
cells from fetal livers (similar fi  ndings occur with EpCAM  cells from adult livers, except that few cells express AFP). (C) Quantitative RT-PCR assays on 
freshly isolated EpCAM  versus EpCAM  cells from fetal versus postnatal livers. These data are compared with the fi  ndings from colonies of hHpSC 
grown on plastic and in serum-free KM for 30  –  60 d.     1976 HUMAN HEPATIC STEM CELLS | Schmelzer et al.
matrix substrata (unpublished data). By 2  –  3 wk, hHpSC col-
onies typically contained many thousands of cells. 
  The hHpSC colonies were assessed for expression of 
lineage markers by immunofl  uorescent staining. The ex-
pression pattern closely resembled that of ductal plate cells 
in vivo. They were positive for CK19, NCAM, EpCAM, 
and CD44H (  Figs. 3, F  –  L  ). In addition, they were positive 
for albumin (weak), E-cadherin, N-cadherin, CK8 and 18, 
CD133/1, integrin      -1 (CD29), claudin 3, and telomer-
ase (unpublished data). They were negative for AFP, any 
form of cytochrome P450, hemopoietic markers (CD34, 
CD45, CD38, CD14, CD90, and glycophorin A), endothe-
lial cell markers (vascular endothelial growth factor recep-
tor [VEGFr], von Willebrand factor, and platelet/endothelial 
cell adhesion molecule or CD31), and mesenchymal markers, 
such as those for hepatic stellate cells (CD146, desmin, and 
     -smooth muscle actin). The expression of NCAM by the 
hHpSCs is important because previous studies have shown 
that this marker is present on the ductal plate in fetal livers 
and evident on liver cell populations proliferating under vari-
ous disease states (  20  –  23  ). 
  Immunoselection using EpCAM isolates hepatoblasts from 
fetal and neonatal livers; immunoselection using EpCAM 
or NCAM isolates hHpSCs from livers of all donor ages 
  To enrich for hepatic progenitors from liver cell suspen-
sions, we explored several fractionation strategies,   including 
cell feeders, yielded parenchymal cell colonies with two dis-
tinct morphologies. Type I colonies consisted of cells forming 
a cordlike morphology interspersed with clear channels and 
expressing EpCAM, albumin, CK19, ICAM, and AFP, but 
not NCAM (Figs. S1  –  S4, available at http://www.jem.org/
cgi/content/full/jem.20061603/DC1). Type 2 colonies con-
sisted of densely packed, morphologically uniform cells, 
strongly expressing EpCAM, NCAM, CD44H, and claudin 
3; weakly expressing or negative for albumin; and negative for 
AFP and ICAM-1 (  Fig. 3   and Fig. S3).   We interpret the type 
1 colonies as corresponding to hepatoblasts and the type 2 
colonies as corresponding to hHpSCs (  Table I  ).   
  In cultures on plastic, by 5  –  7 d (mean 5.2   1.6 d; maxi-
mum number of days), the hepatoblast colonies disappeared. 
However, if cultured on STO feeders, hepatoblasts survived 
for up to 2 mo, continuing to show coexpression of albumin, 
AFP, and CK19 (Figs. S1 and S2). The hepatoblast colonies 
typically contained fewer than     100 cells. 
  In contrast to hepatoblasts, hHpSC colonies on plastic con-
tinued to expand. A time-lapse sequence of a growing hHpSC 
colony (  Fig. 3, A  –  E,   and Video 1, available at http://www
.jem.org/cgi/content/full/jem.20061603/DC1), in which the 
expansion of hHpScs seeded at very low density is shown 
on day 1, 3, and 8. The hHpSCs can be subcultured after me-
chanical disaggregation and continue to multiply extensively. 
Their doubling time on plastic is     36 h. That doubling time 
decreased to  24 h if they are plated on specifi  c extracellular 
  Figure 3.     hHpSCs in culture. A  –  D show a stem cell colony forming at 2 (A), 4 (B), 7 (C), 10 (D), and 14 d (  14  ) in culture on plastic and in KM. Phase 
contrast coupled with image of cells with staining for NCAM (E and F), CK19 (G and H), EpCAM (I and J), and CD44H (L). F and G are the phase and immuno-
histochemistry (IHC) for CK19; H and I are the phase and IHC for NCAM; J and K are the phase and IHC for EpCAM; and L is the IHC for CD44, the 
hyaluronan receptor. Bar, 20     m.   JEM VOL. 204, August 6, 2007 
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0.7% EpCAM  cells. The immunoselected population con-
tained 81% EpCAM  cells, whereas the fl  owthrough fraction 
was almost entirely depleted of EpCAM+ cells. The majority 
of hepatic EpCAM  cells were of 8  –  10  m in diameter, as 
judged by Coulter Counter analysis, in contrast to 18  –  20  m 
for diploid hepatocytes, which is the predominant population 
in the initial liver cell suspension. A small peak of presump-
tive tetraploid cells also is evident, measuring     25  m in 
diameter. Light scatter (  “  side scatter  ”  ) profi  les indicate that 
the EpCAM+ liver cells are considerably smaller and less 
granular than the bulk of the parenchymal cell population. 
  Magnetic immunoselection for NCAM  cells from fe-
tal livers enriched for cells capable of forming only hHpSC 
colonies (  Fig. 4  ). The majority of EpCAM  cells from fe-
tal liver coexpressed NCAM, whereas only     40% of those 
from adult liver were also NCAM . Therefore, sorting for 
NCAM  cells proved useful for isolation of hHpSCs from 
fetal livers, but less so from adult livers. It is unknown at 
this time whether NCAM and EpCAM coexpression is a 
separation by buoyant density on Ficoll gradients (Table 
S1, available at http://www.jem.org/cgi/content/full/jem
.20061603/DC1) and by immunoselection. The most satis-
factory results were obtained using magnetic immunoselec-
tion. Although FACS was able to yield highly purifi  ed cellular 
subpopulations, the shear forces and the use of buff  ers (PBS) 
that are not optimal resulted in low yields of viable cells. 
We used magnetic microspheres conjugated with monoclo-
nal antibody to EpCAM (Miltenyi Biotec) to immunoselect 
EpCAM  cells from liver cell suspensions and obtained ro-
bust, highly viable sorted cells that survived and expanded 
well when cultured (  Fig. 4   and Table S2).   From postnatal 
livers, up to 10 billion viable cells were processed in a single 
pass using the CliniMACS apparatus (Miltenyi Biotec). This 
yielded  100 million EpCAM  cells. Purity of the enriched 
EpCAM  cells was typically 75  –  90%, and recovery usually 
exceeded 90%. Representative fractionations of a fetal liver 
and of a postnatal liver are depicted in   Fig. 4  . A cell suspen-
sion from the liver of a 2-yr-old donor was found to contain 
    Table I  .  Antigenic profi  les of hHpSC and hepatoblasts 
Markers hHpSCs on plastic 
and in KM    1   
hHpSCs     on STO feeders 
and in KM    1   
Hepatoblasts
AFP    2   _     in those from fetal liver;       in those from 
postnatal livers
Albumin    2         or        
P450-3A4    2           
P450-A7    2         
CK 8/18, CD29, CAM 5.2        
CK19  2        particulate staining in cytoplasm
EpCAM  2 
    
  Cytoplasm and membrane    at membrane surface but not cytoplasm
NCAM    2            
Indian Hedgehog    ; in center of cells   
Sonic Hedgehog     at periphery of cells   
ICAM-1    2          (  Fig. 6  )
Claudin 3    2            
CD44H     4           
CD133/1    2           
Telomerase    5           
CD117    2   Debatable    9       
Mesenchymal    6     cell markers          
Endothelial cell markers    7       
Hemopoietic markers    8       
   , weakly expressed;   , expressed strongly;    , expressed very strongly.
   1    Description of KM development (  9  ) and a review for its details of its preparation have been previously provided (56).
  2    Phenotypic characterization of      20 genes by RT-PCR and Western blot analyses was done on hHpSCs, hepatoblasts, and hepatocytes from livers from donors 
of varying age (  16  ).
  3    More extensive studies on hedgehog signaling are presented elsewhere (  39  ).
  4    More extensive studies on hyaluronan receptors and their relevance to use of hyaluronan hydrogels for ex vivo maintenance of hHpSCs are given elsewhere (57).
  5    Telomerase activity has been measured in hHpSCs, hepatoblasts versus in mature liver cells (unpublished data).
  6    Mesenchymal markers: CD146, desmin, and      -smooth muscle actin.
  7    Endothelial cell markers: VEGFr (also called KDR), Von Willebrand factor, and CD31.
  8    Hemopoietic cell markers: CD45, CD34, CD14, CD38, Thy 1 (CD90), and Glycophorin A.
  9    It is not detected on freshly isolated EpCAM  cells from fetal or postnatal livers. RNA for it is enriched in EpCAM  cells (  16  ). It is variably found in hHpSC colonies from 
fetal but not adult livers and, when found, it is always near or overlapping with the companion cells. Immunoselection for it does not yield hHpSCs. We suspect it is on 
angioblasts, but not the hHpSCs (and for certain is not on hepatoblasts).1978 HUMAN HEPATIC STEM CELLS | Schmelzer et al.
albumin and CD133. Evaluations of many preparations indi-
cated that  90% of the EpCAM  cells are positive for 
CD133, which was detected with monoclonal antibodies to 
two distinct epitopes (CD133-1 with monoclonal antibody 
AC133; CD133-2 with monoclonal antibody AC141). Vir-
tually all CD133-1  cells in adult liver cell suspensions were 
found in the EpCAM -selected fraction, and mature hepa-
tocytes were clearly negative. However, it appeared that 
    40% of liver cells with light scatter profi  les consistent with 
mature hepatocytes were positive for CD133-2. Examination 
by immunofl  uorescent microscopy showed that staining for 
CD133-1 clearly outlines cell membranes, whereas that for 
CD133-2 shows a more diff  use pattern (unpublished data). It 
is likely that the staining of many more liver cells by CD133-
2 results from a known cross-reactivity with CK18 (  24  ) that 
is expressed by hepatocytes and can reportedly be found on 
the cell surface (  25  ). Based on the more specifi  c CD133-1 
defi  nitive property of hHpSCs. An alternative hypothesis, 
which is currently being tested, is that NCAM is present on 
angioblasts or other mesenchymal companion cells that are 
tightly bound to the hHpSCs such that immunoselection for 
it results in coselection of the two cell types (see later in this 
paper for more on this theme). Sorts for KDR (VEGFr) re-
sulted mostly in angioblasts (  Fig. 4  ). However, these sorts also 
yielded an increase in hHpSC colonies caused by, we assume, 
coselection of hHpSCs and angioblasts. 
  Proteins and genes expressed by EpCAM+ cells 
  Immunoselected EpCAM  cells from fetal and postnatal liv-
ers were examined by fl  ow cytometry for expression of lin-
eage markers characteristic of various cell types that reside in 
the liver (  Figs. 2 and 4   and Table S1). As judged by double-
label fl  ow cytometry,     95% of the immunoselected EpCAM+ 
cells expressed CK19, and comparable percentages expressed 
  Figure 4.     Magnetic immunoselection. (A  –  F) Flow cytometry on human fetal liver cells stained for EpCAM (D; A is the isotype control for D used for 
setting the gate shown in pink) indicated 20.7% of the cell suspension was positive for EpCAM. The cells were subjected to magnetic bead sorting and 
yielded a suspension enriched for EpCAM to 54.6% of the cells (B is the isotype control used for the data in E). The fl  ow-through cells (F; C is the iso-
type control for F) were depleted in EpCAM, yielding 7.15% of the cells. (G  –  I) Flow cytometry on cells from adult livers. EpCAM expression (y axis) versus 
side scatter (x axis). In the original, unfractionated cell suspensions were found in 0.73% EpCAM  cells. (H) A single pass through microbead sorting 
resulted in enrichment for EpCAM  cells to 80.9%. (I) Only 0.06% EpCAM  cells were found in the fl  owthrough. (J) The EpCAM+ cells were    9 – 10   m 
in diameter versus 18  –  22  m in diameter for mature parenchyma. EpCAM  cells had low side scatter (K) relative to that found for mature cells in the 
unfractionated mixture (UMIX) of liver cells (L). The table shows a summary of profi  les of cells immuno  selected for EpCAM, NCAM, KDR (VEGFr), or for 
KDR-/EpCAM  cells. Phase micrograph images are of an hHpSC colony from an EpCAM  and an NCAM   sort.   JEM VOL. 204, August 6, 2007 
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from postnatal livers strongly enriched for transcripts encoding 
EpCAM, CK19, CD133, and CD117 (c-Kit); these transcripts 
were barely detectable in the EpCAM  cells. AFP transcripts 
were not detectable in EpCAM  or EpCAM  cells from 
postnatal livers. 
  Although immunoselected cells are enriched for relative 
expression of CD117 mRNA, we have not observed the cor-
responding protein by immunostaining of freshly isolated 
cells from fetal or postnatal livers, or on cultured cells from 
postnatal livers. However, we have occasionally observed 
low levels of CD117 staining on cells at the periphery of 
hHpSC colonies from fetal livers that are located in regions 
where hHpSCs overlap with mesenchymal companion cells. 
  Cytochrome P450 3A4 (CYP3A4), which is a protein ex-
pressed by mature hepatocytes, was not found at all in paren-
chymal cells, either EpCAM  or EpCAM , from fetal livers 
in terms of both mRNA and protein level of it. The level of 
mRNA for cytochrome P450 in EpCAM  cells was 20-fold 
lower relative to EpCAM-negative cells from postnatal livers. 
The small amount of CYP3A4 RNA in the EpCAM  cell 
fraction from postnatal livers could be accounted for by resid-
ual hepatocyte contaminants. In contrast, the hepatoblasts, but 
not the hHpSCs, were found to express P4503A7, which is a 
protein found in fetal livers (unpublished data). EpCAM+ 
cells from postnatal livers also showed eightfold lower relative 
expression of albumin RNA than the fl  ow-through (EpCAM-
negative) population. Again, some transcripts can be attributed 
to incomplete removal of hepatocytes. However, the de-
tection of albumin protein in EpCAM  cells by fl  ow cytom-
etry, together with the transcript data, demonstrates that these 
progenitor cells express the albumin gene, albeit at a signifi  -
cantly lower level than diff  erentiated hepatocytes. 
  Assays for telomerase activity indicate signifi  cant levels in 
freshly isolated EpCAM  cells from livers of all donor ages 
antibody, we conclude that EpCAM and CD133 (prominin) 
are coexpressed by the vast majority of hHpSCs. 
  NCAM (CD56), which was previously shown to be ex-
pressed by glia, muscle cells, and neurons (  26  ), was found on 
the majority of hHpSCs derived from fetal and neonatal livers, 
but only     40% of the EpCAM  cells from adult livers. In our 
prior studies, NCAM mRNA was enriched strongly in Ep-
CAM  cells from both fetal and postnatal livers, but expres-
sion at the protein level was variable (  17  ). NCAM staining was 
most evident at the borders of the hHpSC colonies (  Fig. 3  ). 
  Less than 1% of the enriched EpCAM  cells stained for the 
hemopoietic marker CD45 (leukocyte common antigen), 
which is found on Kupff  er cells (tissue macrophages) and lym-
phocytes in the liver. The EpCAM  cells were negative for 
expression of other hemopoietic markers assayed (CD34, CD14, 
CD38, CD4, CD90, and glycophorin A), for endothelial cell 
markers (CD34, VEGFr or KDR, von Willebrand factor, and 
CD31), and for mesenchymal markers, especially those associ-
ated with hepatic stellate cells (CD146, also called Mel-CAM, 
desmin, and      -smooth muscle actin; unpublished data). Finally, 
we found AFP expression at the RNA and protein levels in 
EpCAM  cells from fetal and neonatal livers, but not from 
pediatric or adult livers. As noted, small numbers of cells weakly 
positive for AFP, as judged by immunohistochemistry, were 
observed to be tethered to the ends of the Canals of Hering in 
sections from pediatric and adult livers (  Fig. 1 E  ). In our experi-
ence, these cells are too few and express AFP too weakly to per-
mit recognition as a defi  ned subpopulation by fl  ow cytometry. 
  Assessment by RT-PCR of RNA expression in the 
EpCAM+ liver cells (  Fig. 2  ) gave results consistent with the 
fl  ow cytometry data. Further details of these fi  ndings are 
reported elsewhere (  17  ). In brief, EpCAM  selection from 
fetal livers more than doubled the expression levels of albu-
min, AFP, and CK19. Immunoselection for EpCAM  cells 
    Table II.    Evidence for self-renewal 
 hHpSCs Hepatoblasts
Minimum conditions for survival  KM    1       culture plastic KM    1       STO Feeders 
Lifespan of cells Culture plastic:      6 mo 
  STO feeders: indefi  nite
Plastic: no survival after     5  –  8 d 
  STO feeders:     2 mo
Doubling time on plastic or feeders    2   Plastic:  1.5  –  2 d 
  STO feeders: 12  –  24 d 
  (     24 h on certain matrix substrata    4    )
Plastic: no survival 
  STO Feeders: essentially no growth
    2    Cell number/colony after 2 wk 
(  “  clonogenic  ”   expansion) 
Plastic: 1.4       10  3     5.2       10  2   
  (derived from a single hHpSC partnered with a 
single companion cell; Videos 1  –  3)
Plastic: no survival
Phenotype of hHpSCs after       150 
divisions (     6 mo in culture)
Identical to that of cells after initial plating; 
characterization summarized in Table I
Within the     2 mo of survival time on STO feeders, cells retained 
expression of albumin, AFP, and CK19
Ability to form liver tissue after 
transplantation     3   
Capable after 1  –  2 mo in culture on plastic and 
in KM    1   
Only if transplanted within     7 d of culture on plastic 
  (not tested with cells on STO feeders)
  1  KM    serum-free RPMI 1640 with no copper, low calcium (0.3 mM), and supplemented with zinc, selenium, insulin, transferrin, HDL, and lipids (  12  ).
  2    See Videos 1  –  3, which show colony formation at low seeding densities and over days 1-8. Clonogenic expansion occurs, but requires each hHpSC to be partnered with at 
least one companion cell; the companion cells proved to be angioblasts or hepatic stellate cell precursors (  Fig. 5  ).
  3    In   Fig. 8  , images from liver sections from animals transplanted with hHpSCs are shown.
  4    Elsewhere, we report that plating the stem cells onto specifi  c forms of extracellular matrix, found in abundance in embryonic or fetal tissues enables them to go for months 
through rapid divisions with doubling times of      24 h (unpublished data).1980 HUMAN HEPATIC STEM CELLS | Schmelzer et al.
with only the native feeders (the companion cells) (  Table II  ).   
The cells maintained phenotypic stability as assessed by mor-
phology and by antigenic and biochemical profi  les (Tables 
1 and 2). hHpSC colonies starting from 1  –  3 cells (Videos 
1  –  3, available at http://www.jem.org/cgi/content/full/jem
.20061603/DC1) grew to cover 4.9   0.3 mm  2   in area and 
contained an average of 1,400   520 cells (3 independent 
counts of total cells from 50 dispersed colonies). Thus, the 
cells in this representative experiment had gone through 
10  –  11 population doublings in 2 wk, corresponding to an 
average doubling time of 31  –  34 h (Table S2). 
  Mesenchymal companion cells provide critical paracrine 
signaling for hHpSCs 
  The tightly packed colonies of hHpSCs have a prominent 
ridge at the perimeter (  Figs. 3, 4, and 6  ) at which we have 
identifi  ed mesenchymal companion cells (  Fig. 5  ).   As the col-
onies grow, the companion cells penetrate the colonies and 
are found throughout them. Time-lapse movies (Videos 1  –  3) 
reveal a boundary zone between the companion cells and the 
hHpSCS in which the companion cells fl  uctuate back and 
forth, touching the edge of the hHpSC colony, or traversing 
it and moving below the colony. When removed from a culture 
and in cultures of colonies of both hHpSCs and hepatoblasts. 
Full characterization of telomerase activity and its regulation 
in various fractions of human liver cells from fetal and post-
natal donors is presented elsewhere (unpublished data), as are 
studies on the eff  ects of purifi  ed matrix substrata on telomer-
ase activity in cultures of hHpSCs (unpublished data). 
  Ex vivo clonogenic expansion: evidence for self renewal 
  Colony formation by committed hepatic progenitors or dip-
loid adult parenchyma involves a limited number of divisions 
(typically 5  –  7 divisions) over a relatively short period of time 
(2  –  3 wk) (  8  ). In contrast, self-renewal involves clonogenic 
expansion that can go on for  100 population doublings 
with phenotypic stability, which are properties associated 
with stem cells. We previously found that rat hepatoblasts 
multiply far more extensively in KM with STO feeder cells 
than on tissue culture plastic (  8  ). However, STO feeders and 
KM were not permissive for clonogenic expansion of hu-
man hepatoblasts. Under these conditions, the hepatoblasts 
survived for a few months, but demonstrated limited growth. 
In contrast, hHpSCs from livers of all donor ages could un-
dergo clonogenic expansion for  6 mo ( 150 population 
doublings) in culture on tissue culture plastic and in KM 
  Figure 5.     Companion cells to the hHpSC colonies comprise hepatic stellate cells and angioblasts. hHpSCs are associated with mesenchymal 
companion cells with distinct antigenic profi  les (Videos 1  –  3). Two types of companion cells are evident: angioblasts (positive for VEGF-R, CD133/1, and 
CD117, and weakly positive for CD31 and von Willebrand  ’  s factor) and hepatic stellate cells (positive for desmin and      -smooth muscle actin [aSMA]). 
Videos 1  –  3 are available at http://www.jem.org/cgi/content/full/jem.20061603/DC1.     JEM VOL. 204, August 6, 2007 
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genic, and biochemical profi  les identical to that of hepatoblasts. 
The cells in these erupted areas strongly expressed AFP, 
ICAM-1, and albumin, and were positive for cytochrome 
P450-A7 (not depicted), but were negative for NCAM (  Fig. 7  ). 
In addition, committed biliary progenitors were sometimes 
observed erupting from a colony of hHpSCs, as shown by 
staining for CK19, but not for albumin (  Fig. 7  ). 
  In cultures of cells from postnatal livers, in colonies stained 
by double-label immunofl  uorescence for CK19 and albumin, 
we have observed distinct sectors positive for one or the other 
marker, but not both (Fig. S4). This was found most fre-
quently in colonies of hepatoblast morphology. We interpret 
such sectors as deriving from unipotent cells, corresponding 
to committed progenitors for biliary and hepatocytic lineages, 
respectively. The sectoring could occur if at division a bipo-
tent cell gives rise to a daughter cell that was restricted to the 
biliary or to the hepatocytic lineage. Occasionally, small colo-
nies showed expression of only one of the lineage markers 
(CK19 or albumin); these colonies are assumed to have arisen 
from committed progenitors for the corresponding cell type. 
  EpCAM+ cells and colonies of hHpSCs give rise to human 
liver tissue in vivo 
  Transplantation of freshly isolated EpCAM  cells or of 
hHpSC colonies, from either fetal or postnatal livers, into liv-
ers of NOD/SCID mice resulted in engraftment and the for-
mation of human liver tissue (  Fig. 8  ).   Islands of cells staining 
positive for human albumin, CK19, and AFP were found 
within 2 d of transplantation (  Fig. 8, A, C, and E  ), and they 
persisted within the livers for weeks (  Fig. 8 F  ). The extent of 
engraftment and expansion of human liver cells in vivo was 
enhanced by treatment of the mice with carbon tetrachloride 
(CCL4), which is a poison for the pericentral zone of the liver 
acinus and is often used to create a cellular vacuum in trans-
planted hosts (  Fig. 8, B, D, and G  ). Human-specifi  c DNA se-
quences were found in the liver of animals that received the 
dish, the attachment to the plastic surface is evident only at 
the edge of the colonies, not in the center. This suggests that 
attachment to the plastic is mediated either by mesenchymal 
cells or by cooperative interactions between the hHpSCs and 
the mesenchymal cells. 
  Phenotypic analyses of the companion cells indicates at 
least two distinct populations: angioblasts (VEGFr  or KDR, 
CD133/1 , CD117 , Von Willebrand factor, CD31  weak  ); 
and hepatic stellate cells (desmin+,      -smooth muscle actin , 
CD146 ) (  Fig. 5  ). A comparison of their morphological and 
antigenic phenotypes is given in   Fig. 5  . Cells rigorously puri-
fi  ed away from the companion cells (by repeated immuno-
selection for EpCAM  cells) did not survive on culture plastic, 
but only on STO feeders (unpublished data). Immunoselec-
tion of CD117  cells yielded angioblasts, but neither hepatic 
stellate cells nor hHpSCs (unpublished data). Immunoselec-
tion for other markers found on the companion cells (VEGFr) 
resulted mostly in selection of the companion cells alone, 
though we did fi  nd coselection for hHpSCs to occur at low 
and variable frequency (  Fig. 4  ). We still cannot rule out that 
the consistent enrichment of hHpSCs from fetal liver by 
immunoselection for NCAM could actually result from cose-
lection of the stem cells via tight association with NCAM  
companion cells. 
  Proof of pluripotency of hHpSCs 
  Passaging (transfer) of colonies of hHpSCs (whether derived 
from fetal or adult livers) from culture plastic onto feeder lay-
ers of STO cells resulted, within hours, in eruption of hepa-
toblasts from the periphery of hHpSC colonies (  Figs. 6 and 7  ; 
  Table I  ).   After the transfer, the morphology and antigenic 
profi  le of the cells within the hHpSC colonies proper did not 
change in most of the cells, although there were occasional 
cells with distinct gene expression within the colony (  Fig. 7  ). 
Instead, the colonies of hHpSCs gave rise to cordlike erup-
tions from their edges, yielding cells with morphology, anti-
  Figure 6.     hHpSCs shifted to STO feeders erupt hepatoblasts. Passage of hHpSCs from plastic to STO feeders results in cordlike eruptions that 
morphologically and antigenically are identical to hepatoblasts. (A) An hHpSC colony shortly after passaging. (B  –  E) A small group of passaged stem cells 
appears as a tightly compacted group of cells with cords of hepatoblasts erupting at the periphery of the colonies. Shown is a colony and the steady 
eruption of hepatoblasts by the end of day 1 (B), 3 (C), 5 (D), and 7 (E) after passaging.     1982 HUMAN HEPATIC STEM CELLS | Schmelzer et al.
  As an independent test of engraftment, we assessed ex-
pression of the human transferrin gene, encoding a protein 
characteristic of mature hepatocytes. We found by quantita-
tive RT-PCR analysis with human-specifi  c primers that the 
livers of mice sampled 1 wk after injection of the EpCAM  
cells derived from postnatal human livers contained signifi  -
cant levels (2,100   1,140 strands/100 ng) of human trans-
ferrin RNA. Such sequences were undetectable in RNA 
from livers of control mice ( 100 strands/100 ng RNA). Al-
though before transplantation  80% of cells in the test cell 
population expressed EpCAM and CK19, cells in recipient 
animals were positive for human albumin and were negative 
for both of the progenitor cell markers. Collectively, the data 
suggest that within 7 d in vivo, the engrafted hHpSCs gave 
rise to mature human liver cells. 
    DISCUSSION   
  Cells in the ductal plates in fetal and neonatal livers and in the 
Canals of Hering in pediatric and adult livers are hHpSCs. 
human cell transplants, but not in other tissues or in control 
animals that did not receive human cells (unpublished data). 
Before transplantation, as expected, the cells were shown to 
express EpCAM and CK19 strongly and albumin weakly, but 
were negative for AFP at both the RNA and the protein lev-
els. The liver sections from mice transplanted with hHpSCs 
contained cells strongly expressing human-specifi  c forms of 
albumin, CK19, and AFP, but were negative for EpCAM. 
However, human cytochrome P450 3A was not detectable. 
Therefore, it appears that after transplantation and expansion 
in recipient livers, the human cells lost expression of a marker 
(EpCAM) found only on stem and progenitor cells, and, 
acquired some, but not yet all, of the functions specifi  c to 
mature hepatocytes. We think it logical that transferrin, but 
not P450 3A, is expressed in transplanted cells given that in 
mature liver, transferrin is expressed by zone 2 parenchymal 
cells, whereas P450 3A by zone 3 parenchymal cells within 
the acinus. Thus, P450 3A is a late gene produced by cells at 
the end of the liver  ’  s maturational lineage. 
  Figure 7.     Shift in antigenic profi  le from hHpSCs to hepatoblasts when on STO feeders. (A and B) The border between the hHpSC colony and 
hepatoblast outgrowths is marked by arrowheads. (C and D) The antigenic profi  le of the cords of cells erupting from the parent colony is identical to that 
of hepatoblasts and includes a shift from expression of NCAM (green) to ICAM (red). Lineage restriction to committed biliary progenitors (CBPs) indicated 
by staining for CK19 (green) and albumin (red). (E and F) expression of AFP (green) and albumin (red) indicates that erupting cells are hepatoblasts.     JEM VOL. 204, August 6, 2007 
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have long been considered hepatic stem cells (  28  ). However, 
AFP  −   hHpSCs are actually precursors to hepatoblasts. 
  Recognition of the ductal plate as the liver  ’  s stem cell 
niche provides a new insight into organogenesis. The speci-
fi  cation of foregut cells to a hepatic fate is associated with 
expansion of endoderm into the surrounding cardiac mesen-
chyme, a process leading to ductal plate formation (  27  ). Our 
data suggests that ductal plates are directly antecedent to the 
Canals of Hering, which have been identifi  ed as the reservoir 
of stem cells in postnatal livers (  18, 29  ) 
  At all ages, the liver displays a remarkable capacity to 
regenerate after physical or toxic injury (  1  ). Two forms of 
regenerative response are known. The fi  rst is a hypertrophic 
cellular response by mature hepatocytes that undergo DNA 
synthesis with minimal cytokinesis, which is the predominant 
They can be isolated effi   ciently by selective culture condi-
tions and by immunoselection for EpCAM (CD326) and/or 
NCAM (CD56). The hHpSCs have features typical of stem 
cells including Sonic and Indian Hedgehog signaling (  27  ) and 
high telomerase activity (unpublished data). They are capable 
of self-renewal, as shown by clonogenic expansion for  150 
population doublings, and are pluripotent, with the ability to 
give rise directly to committed biliary progenitors and hepa-
toblasts, and thence to hepatocytic and biliary lineages, as well 
as to other endodermal cell types (our unpublished data). The 
hHpSCs express certain markers of both hepatocytic and biliary 
lineages, but lack expression of mature liver functions (  17  ). 
They yield human liver tissue when transplanted intrahepati-
cally in immune-defi  cient mice. Hepatoblasts, expressing AFP, 
albumin, and CK19, and emerging in newly forming liver tissue, 
  Figure 8.     Transplantation of EpCAM cells (or colonies of stem cells in culture) results in engrafted liver tissue in NOD/scid mice. NOD/scid mice 
were transplanted with 10  6   cells of either freshly isolated and immunoselected EpCAM  cells or colonies of hHpSCs from culture on plastic for 30  –  60 d (more 
than     40 population doublings). Similar results were obtained with both populations. After transplantation, half the mice were treated with CCL4 (representa-
tive results shown in B, D, and F; representative results from transplanted mice not treated with CCL4 are shown in A, C, E, and F. A, C, and E show sections 
of murine livers stained for human-specifi  c proteins 2 (A, C, and E), 8 (F), or 8 d after transplantation and 7 d after CCL4 treatment (B, D, and G). Controls 
included sections of mice not transplanted (H) or sections stained with only the secondary antibody (I). All antibodies, except for the antibody to albumin, gave 
little or no background; the control for albumin is shown. The arrows denote the location of human liver tissue within the section of murine liver tissue.    1984 HUMAN HEPATIC STEM CELLS | Schmelzer et al.
of EpCAM is believed to diminish the eff  ectiveness of E-cad-
herin binding through impairment of the inter  action be-
tween      -catenin and the actin cytoskeleton (  16  ). This role 
may be physiologically relevant for hHpSCs and hepato-
blasts, as E-cadherin was expressed with the same distribution 
as EpCAM. 
  The role of NCAM in the biology of hHpSCs requires 
further elucidation. We found that the hHpSCs from fetal and 
neonatal liver consistently show strong NCAM expression, 
and that immunoselection for NCAM enriches for hHpSCs. 
However, only     40% of hHpSCs from adult livers are posi-
tive for this antigen. In cultures of hHpSCs, NCAM expres-
sion is observed in a characteristic scalloped pattern located 
most prominently at the borders of the colonies. Thus far, 
we have not been able to ascertain unequivocally whether 
NCAM is expressed by hHpSCs, by tightly associated mes-
enchymal companion cells, or both. Ultrastructural studies by 
electron microscopy are needed to resolve this point. NCAM 
is a member of the Ig superfamily, with  20 alternatively 
spliced mRNAs encoding multiple protein isoforms (  22, 37  ). 
It is the only sialated cell adhesion molecule, and it forms 
homotypic cell  –  cell attachments that are inversely propor-
tional to the degree of sialation; an increase in sialation re-
sults in muted cell  –  cell adhesion and consequent increase in 
migration and invasion (  22  ). Several groups have reported 
that NCAM is expressed by ductal plate cells within the fetal 
liver and, interestingly, also by proliferative ductular cells that 
characterize pathologies collectively termed ductal plate mal-
formations, such as primary biliary atresia (  20, 38  –  41  ). Thus, 
positive staining for NCAM, in addition to albumin, CK19, 
and CK8/18, supports the interpretation of these cells as ones 
derived from the ductal plate. 
  We found consistent expression of CD133 (prominin-1) 
by hHpSCs cultured on both plastic and on STO substrata, 
and by  90% of EpCAM  cells immunoselected from adult 
livers. Although angioblasts also are CD133 , the staining in 
hHpSC colonies was associated with most or all cells, indicat-
ing that CD133 is expressed by the hHpSCs and not only by 
companion cells. This pentaspan transmembrane glycoprotein 
was fi  rst identifi  ed on hematopoietic stem cells, and its expres-
sion also has been observed on stem/progenitor cells of a vari-
ety of lineages, including endothelia, muscle, neural, prostatic, 
epidermal, and others (  42, 43  ). The role, if any, of CD133 in 
the self-renewal and diff  erentiative capacity of hHpSCs is not 
yet understood. However, it may be signifi  cant that an isoform 
of CD133 specifi  cally associated with stem cells was found in 
cells of the basal layer of human neonatal epidermis, and co-
expressed there with integrin      -1, which is also expressed by 
hHpSCs and hepatoblasts. Furthermore, CD133 expression 
was lost as the epidermal cells stopped proliferating and ac-
quired a diff  erentiated phenotype in culture (  44  ). 
  Association of mesenchymal   “  companion  ”   cells 
with hHpSCs 
  The specifi  c association of multiple adhesion molecules with 
hHpSCs and hepatoblasts suggests that they play important 
mechanism of regeneration after partial hepatectomy in post-
natal livers (  30, 31  ). The other is a hyperplastic response by both 
progenitor cells and diploid hepatocytes after signifi  cant loss of 
liver cells in zones 2 and 3, as previously detailed (  2, 32, 33  ). 
Contributions of progenitors to regeneration after partial 
hepatectomy have been presumed negligible based on as-
sumptions that they should be AFP  (  1  ). Because hHpSCs 
are AFP-, their role in liver regeneration in adults requires re-
evaluation by tracking the involvement of EpCAM  and 
NCAM  cells. The frequency of EpCAM  cells in suspen-
sions prepared from postnatal human livers is consistent at all 
ages beyond a few months, in the range of 0.5  –  2.5%. We in-
fer that a substantial pool of hHpSCs is maintained through-
out life. The number of hHpSCs is much higher than estimates 
based on the frequency of AFP  cells ( 0.01%). Some au-
thors have argued that the mature liver contains only   “  faculta-
tive  ”   stem cells, which are activated in response to pathological 
states and injuries that invoke a hyperplastic response (  3, 18, 
33, 34  ). We have previously raised the alternative hypothesis 
that hHpSCs function routinely to replenish the liver as 
mature cells are lost slowly through terminal diff  erentiation 
(  17, 35, 36  ). The presence of a much larger pool of hHpSCs 
than previously suspected in normal adult livers provides a 
further rationale to examine this possibility more carefully. 
  During development, a limited number of hHpSCs are 
associated with developing portal tracts and steadily give rise 
to hepatoblasts that we hypothesize are the liver  ’  s transit-
amplifying cells. The hepatoblasts, in turn, are precursors to 
committed hepatocytic and biliary progenitors. Further evi-
dence for hepatoblasts in normal adult livers is given elsewhere 
(unpublished data). In the fi  ndings reported in this work, we 
show the generation of hepatoblasts and unipotent progenitors 
from hHpSC colonies in culture. This occurs spontaneously 
from discrete regions at the periphery of hHpSC colonies and 
may correspond to a localized signal that triggers a rapid burst 
of expansion from one or more cells. As noted below, cell  –  cell 
interactions are key to both maintenance and diff  erentiation of 
hHpSCs. STO feeder cells promote diff  erentiation of hHpSCs, 
whereas they contribute primarily to survival and expansion of 
rodent hepatoblasts, and may off  er a tool to identify some of 
the diff  erentiation-promoting signals for hHsPCs. 
  Functions of cell surface markers of hHpSCs 
  Characteristic cell surface antigens of hHpSCs and hepato-
blasts overlap extensively, with both populations expressing 
EpCAM, E-cadherin, integrin      -1 (CD29), and CD133. The 
hHpSCs and hepatoblasts are negative for markers of hema-
topoietic (CD34, CD45, CD38, CD14, CD90, and glycopho-
rin A), endothelial (VEGFr, von Willebrand ’  s factor, and CD31), 
and mesenchymal (CD146, desmin, and      -smooth muscle 
actin) cell lineages. 
  EpCAM is present on proliferating epithelial cells in most, 
if not all, organs derived from endoderm (liver, lung, pan-
creas, and intestine). The extracellular domain of EpCAM 
is  thought to generate a relatively weak homotypic bond 
between adjacent cells (  15  ). Conversely, the cytosolic   domain JEM VOL. 204, August 6, 2007 
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mesenchymal cell markers are also an example of coselec-
tion (  51  ). 
  The hHpSC populations from both fetal and adult livers 
appear essentially negative for CD45, CD34, and CD117. 
However, CD34 and CD117 are expressed by angioblasts, 
which we have found in companion cells associated with 
hHpSCs. Based on immunofl  uorescent  staining,  CD117 
was variably present in the border zone between the com-
panion cells and some (but not all) hHpSC colonies cultured 
on plastic. Also, transcript analysis revealed a slight enrich-
ment in CD117 mRNA in EpCAM  cell populations from 
fetal livers and a signifi   cantly greater enrichment in Ep-
CAM  cells from postnatal livers (  17  ). Nonetheless, im-
munoselection for CD117 or CD34 yielded angioblasts, not 
hHpSCs. In summary, our data remain inconclusive; we 
cannot rule out that a minor subpopulation of hHpSCs cells 
express CD117. 
  It is conceivable that phenotypic diff  erences between 
hHpSCs obtained by diff   erent isolation procedures refl  ect 
varying stages within a common lineage and/or subtle eff  ects 
of in vitro selection protocols. However, it is clearly impor-
tant to be aware of the physical and functional interaction of 
hepatic (endodermal lineage) and mesenchymal lineage cells 
both in the developing liver and the adult organ, and the pos-
sibility of ascribing properties to a single cell type that actually 
correspond to a mixed population. In any case, we argue that 
the relative frequency and anatomical location of EpCAM , 
CD133 , and CD34  cells, and the growth and diff  erentia-
tion capacity of these cells, provide strong evidence that the 
hHpSCs described here are authentic stem cells in fetal and 
postnatal livers. 
  Purifi  ed EpCAM  cells from fetal or postnatal livers are 
able to engraft the livers of immunodefi  cient adult mice, with 
or without prior injury, yielding mature human liver tissue. 
The engrafted cells lose expression of stem cell markers 
(EpCAM, CD133, and CK19) and show enhanced expres-
sion of mature human proteins and mRNAs characteristic of 
hepatocytes (albumin and transferrin). The use of human-
specifi  c antibodies and sequence probes confi  rmed that these 
were made by donor origin cells. The extent of humaniza-
tion of the murine livers was greatly enhanced by treatment 
of mice with CCl4, which is known to selectively kill mature 
parenchymal cells, and thereby, to create a cellular vacuum in 
the host. 
  The effi   ciency with which EpCAM  cells can be   isolated 
from human livers, their ability to clonogenically expand ex 
vivo, their pluripotency, and the evidence that they yield 
mature liver tissue after transplantation encourage consider-
ation of their clinical utility. Potential applications include 
cell-based therapies of liver disease and generation of cells for 
bioartifi  cial livers. 
    MATERIALS AND METHODS   
  Human liver sourcing 
  Fetal livers.     Liver tissue was provided by an accredited agency (Advanced 
Biological Resources) from fetuses between 18  –  22 wk gestational age that 
regulatory functions in modulating interactions with cells 
that comprise local inductive environments and/or stem cell 
niches. A critical, enabling event, required for formation of 
the liver, is that angioblasts from the septum transversum in-
duce the hepatic bud to form (  7  ). Such key interactions are 
now amenable to study in vitro using hHpSCs. We observed 
that colony expansion and cell outgrowth of hHpSCs de-
pends on the mesenchymal companion cells that are promi-
nent at the periphery of hHpSC colonies and identifi  ed by 
antigenic profi  les as angioblasts (positive for VEGFr, CD31 
or platelet/endothelial cell adhesion molecule, CD117, and 
CD133) or hepatic stellate cell precursors (positive for CD146 
[MEL-CAM and MCAM], desmin, and      -smooth muscle 
actin). These fi  ndings parallel our prior work defi  ning hepatic 
stellate cell precursors as supportive of rodent hepatic pro-
genitors and in which we fi  nd that they express not only 
vitamin A, desmin, and      -smooth muscle actin but also vari-
ous markers associated with endothelia, such as VCAM (  45  ). 
  CD146 forms homotypic cell  –  cell connections that were 
fi  rst localized on melanoma cells and, subsequently, at cell 
junctions within endothelial cell layers (  46  ). CD146 has now 
been identifi  ed on many diff  erent cell types, including ke-
ratinocytes and hair follicle epithelia, stromal cells in adipose 
tissue and bone marrow, and most cell types in the thymus 
(  47, 48  ). The expression of CD146 on cells at the periphery 
of colonies of hHpSCs, and extending to the innermost cells 
of aging colonies on plastic, is consistent with the known 
anticohesive activity of CD146. In this capacity, CD146 func-
tions as an outside-in transducer that suppresses gap junction 
connections, inhibits     -1  –  mediated integrin binding, and disturbs 
E-cadherin  –  based adherens junctions (  46, 49  ). Furthermore, the 
strong expression of ICAM-1 by more diff  erentiated cells 
emerging from hHpSC colonies may also refl  ect modula-
tion of cell  –  cell interactions. ICAM has been shown to act 
in conjunction with CD146 to disturb E-cadherin  –  based cell 
junctions (  50  ). The dramatic increase in expression of CD146, 
in association with diff  erentiation of the hHpSCs into hepa-
toblasts, is assumed to model angiogenesis in the forming liver, 
an interpretation that is supported by the fi  ndings in a study 
of Sonic and Indian Hedgehog signaling and the Patched re-
ceptor in the ridge formed by the angioblasts and the hepatic 
stellate cells (  27  ). 
  The possibility of coisolation of hHpSCs with mesenchy-
mal cells may account for some apparent diff  erences between 
the hHpSCs described in this work and candidate hHpSCs 
reported by others (  51  ). For example, liver-derived, stemlike 
cells have been reported to express markers shared with 
hematopoietic progenitors, including CD45 (leukocyte com-
mon antigen), CD34, and CD117, and/or to be capable of 
giving rise to both hepatic and endothelial cells (  52  ). Another 
study describes candidate hepatic stem cells found in regener-
ation after massive hepatic necrosis as   “  lymphoid blastlike  ”   
cells that express CD133 and CD117, but not CD45 (  53  ). 
We suspect that the multipotent stem cells found in fetal 
liver and reported to give rise to liver and also mesenchymal 
lineages (cartilage) and that coexpress EpCAM and various 1986 HUMAN HEPATIC STEM CELLS | Schmelzer et al.
  supplemental table 1. In supplemental table 2, we present the number and 
type of colonies obtained after fractionating and plating cells from postnatal 
human livers of various ages. Supplemental fi  gures 1 and 2 show hepatoblast 
morphology, antigenic profi  le, and immunostaining results when cultured 
on plastic or feeder cells. Microscopy images of hepatic progenitors with 
specifi  c immunohistochemistry markers can be seen in supplemental fi  gures 
3 and 4. Clonogenic expansion of hepatic stem cells from days 1, 3, and 8 
can be seen in supplemental movies 1-3. The online version of this article is 
available at http://www.jem.org/cgi/content/full/jem.20061603/DC1. 
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were obtained by elective terminations of pregnancy. The research protocol 
was reviewed and approved by the Institutional Review Board for Human 
Research Studies at the University of North Carolina. 
  Postnatal livers.     Intact livers from cadaveric neonatal, pediatric, and adult 
donors were obtained through organ donation programs via the United 
Network for Organ Sharing. Those used for these studies were considered 
normal, with no evidence of disease processes. Informed consent was ob-
tained from next of kin for use of the livers for research purposes, protocols 
received Institutional Review Board approval, and processing was compliant 
with Good Manufacturing Practice. 
  Liver processing 
  Fetal livers.     All processing and cell enrichment procedures were con-
ducted in a cell wash buff  er composed of a basal medium (RPMI 1640) 
supplemented with 0.1% BSA (BSA Fraction V; Sigma-Aldrich), insulin 
and iron-saturated transferrin (both at 5 ug/ml; Sigma-Aldrich), trace ele-
ments (300 pM selenious acid and 50 pM ZnSO4), and antibiotics (AAS; 
Invitrogen). Liver tissue was subdivided into 3-ml fragments (total volume 
ranged from 2  –  12 ml) for digestion in 25 ml of cell wash buff  er containing 
type IV collagenase and deoxyribonuclease (both at 6 mg per ml; Sigma-
Aldrich) at 32°C with frequent agitation for 15  –  20 min. This resulted in 
a homogeneous suspension of cell aggregates that were passed through a 
40-gauge mesh and spun at 1,200 RPM for 5 min before resuspension 
in cell wash solution. Erythrocytes were eliminated by either slow-speed 
centrifugation (  54, 55  ) or by treating suspensions with anti  –  human red 
blood cell antibodies (1:5,000 dilution; Rockland) for 15 min, followed 
by LowTox Guinea Pig complement (1:3,000 dilution; Cedarlane Labs) 
for 10 min, both at 37  °  C. Estimated cell viability by Trypan blue ex-
clusion was routinely  95%. See Supplemental materials and methods 
for further details (available at http://www.jem.org/cgi/content/full/
jem.20061603/DC1). 
  Postnatal livers.     The livers were perfused through the portal vein and he-
patic artery for 15 min with EGTA-containing buff  er, and then with 600 
mg/liter collagenase (Sigma-Aldrich) for 30 min at 34  °  C. The organ was 
mechanically dissociated in either collection buff  er; the cell suspension 
passed through fi  lters of pore size 1,000, 500, and 150      m; the single cells 
were collected, and live cells were fractionated from dead cells and debris 
using density gradient centrifugation (500   g   for 15 min at room temperature) 
in OptiPrep-supplemented buff  er in a Cobe 2991 cell washer. The resulting 
hepatic cell band residing at the interface between the OptiPrep/cell solu-
tion and the RPMI 1640 without Phenol red was collected. 
  Magnetic immunoselection 
  Isolation of cells expressing EpCAM from human liver cell suspensions was 
performed using the monoclonal antibody HEA-125 coupled to magnetic 
microbeads, and separated using a miniMACS, a MidiMACS, an AutoMACS, 
or a CliniMACS magnetic column separation system from Miltenyi Biotec, 
following the manufacturer  ’  s recommended procedures. Similar protocols 
were used for sorts for NCAM , CD117 , VEGFr (KDR) , CD34 , and 
CD146  cells. 
  Colony formation 
  Cells were plated in serum-free, hormonally defi  ned medium (KM) in 6-
well tissue culture dishes seeded with monolayers of Mitomycin-treated 
STO feeder cells, as described by Kubota and Reid (  8  ). Medium was changed 
every 2  –  4 d. Colonies were observed within 7  –  10 d and were followed for 
up to 6 mo using an inverted microscope (1X-FLAIII; Olympus). 
  Online supplemental material 
  We present details for liver processing, histology, fl  ow cytometry and 
immuno  histochemistry in the supplemental materials and methods avail-
able online. In addition, results of the antigenic profi  le can be found in JEM VOL. 204, August 6, 2007 
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